BioAesthetics is a startup based in the United States, most recent round Series A, 2 tracked investors.
BioAesthetics is a company founded in 2024 headquartered in the United States. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
BioAesthetics develops a tissue-engineered nipple-areolar complex (NAC) graft to improve breast reconstruction options for patients post-mastectomy.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.